Risperdal Consta Medicare Reimbursement Set At 95% Of AWP
Executive Summary
Johnson & Johnson's injectable antipsychotic Risperdal Consta (risperidone) will be reimbursed at 95% of AWP effective April 1 under an update to the Medicare Hospital Outpatient Prospective Payment System
You may also be interested in...
Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes
Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes
Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
“Functional Equivalence” For 2004: Aranesp OPPS Payment Is 78% Of AWP
Medicare will reimburse Amgen's Aranesp at about 78% of AWP under a revised Hospital Outpatient Prospective Payment System rule